{
    "Trade/Device Name(s)": [
        "PF4/PVS Complex IgG Antibody Detection Assay",
        "PF4 IgG",
        "Platelet Factor 4 Assay"
    ],
    "Submitter Information": "Immucor GTI Diagnostics, Inc.",
    "510(k) Number": "K201311",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071781"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCO"
    ],
    "Summary Letter Date": "June 18, 2020",
    "Summary Letter Received Date": "May 18, 2020",
    "Submission Date": "May 15, 2020",
    "Regulation Number(s)": [
        "21CFR864.7695"
    ],
    "Regulation Name(s)": [
        "Platelet Factor 4 Radioimmunoassay"
    ],
    "Analyte Class(es)": [
        "immunology",
        "hematology"
    ],
    "Analyte(s)": [
        "Heparin associated IgG antibodies",
        "Platelet Factor 4 (PF4) antibodies"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Without anticoagulant (Serum)",
        "ACD tube",
        "Sodium Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme linked immunosorbent assay (ELISA)",
        "Colorimetric measurement"
    ],
    "Methodologies": [
        "Qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent",
        "Control",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for Immucor PF4 IgG ELISA assay detecting heparin associated IgG antibodies in serum or plasma for assessment of heparin induced thrombocytopenia",
    "Indications for Use Summary": "Qualitative screening assay for detection of heparin associated IgG antibodies in human serum or plasma, commonly found in patients with Heparin Induced Thrombocytopenia (HIT)",
    "fda_folder": "Hematology"
}